Bioray Biotech Co

Bioray Biotech Co Enterprise Value

The Enterprise Value (EV) of Bioray Biotech Co (7561.TWO) as of Oct 16, 2026 is 727.80 M TWD. In the previous year, Enterprise Value (EV) was 635.37 M TWD — a change of 14.55% (higher).

Enterprise Value

727.80 MTWD

YoY

14.55%

Last updated:

Enterprise Value (EV) of Bioray Biotech Co is 2025 727.80 M TWD. Enterprise Value (EV) of Bioray Biotech Co was 2024 635.37 M TWD. It decreases by 14.55% higher compared to the previous year.

The Bioray Biotech Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
465.88 M TWD
Jan 1, 2019
572.78 M TWD
Jan 1, 2020
643.48 M TWD
Jan 1, 2021
654.96 M TWD
Jan 1, 2022
689.65 M TWD
Jan 1, 2023
700.57 M TWD
Jan 1, 2024
635.37 M TWD
Jan 1, 2025
727.80 M TWD
The Bioray Biotech Co Enterprise Value history
YEAREnterprise ValueYoY
727.80 MTWD+14.55%
635.37 MTWD-9.31%
700.57 MTWD+1.58%
689.65 MTWD+5.30%
654.96 MTWD+1.78%
643.48 MTWD+12.34%
572.78 MTWD+22.95%
465.88 MTWD-13.81%
540.51 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioray Biotech Co Stock analysis

What does Bioray Biotech Co do? Bioray Biotech Co Ltd is a company based in Tainan, Taiwan, operating within the Health Care sector, specifically in the Biotechnology industry. The company went public on July 6, 2020, with its ticker listed as 7561.TWO and ISIN TW0007561B13. Bioray Biotech focuses on the development of biological health products, functional medical testing, and cell storage and preparation services. The company's product portfolio includes personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, and female urinary tract health products. In the functional medical testing segment, the company offers services such as personalized bacteria testing, personalized fungi testing, intestinal normal bacteria analysis, quantitative detection of magnesium in red blood cells, polymorphism analysis of metabolic-related genes, and lymphocyte grouping. For cell storage and preparation, Bioray Biotech provides stem cell storage, immune cell storage, and cytokine-induced killer (CIK) immune cell preparations. The company's website is https://bio-ray.com.tw/, where further information about its services and products can be found. Bioray Biotech is engaged in the development and provision of specialized health-related services and products, primarily targeting personalized health solutions through biotechnology. Bioray Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioray Biotech Co stock

Enterprise Value (EV) of Bioray Biotech Co is 727.80 M TWD in 2025.

Enterprise Value (EV) of Bioray Biotech Co changed from 635.37 M TWD to 727.80 M TWD, representing a 14.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Bioray Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Bioray Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Bioray Biotech Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Bioray Biotech Co